Richard Colvin
Chief Tech/Sci/R&D Officer presso BLUEBIRD BIO, INC.
Patrimonio netto: 151 511 $ in data 31/03/2024
Profilo
Richard Colvin is currently the Chief Medical Officer at bluebird bio, Inc. He previously worked as an Executive Director-Translational Medicine at Novartis, Inc. Dr. Colvin completed his undergraduate degree at Cornell University and obtained a doctorate from Duke University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0.06% | 01/03/2024 | 118 368 ( 0.06% ) | 151 511 $ | 31/03/2024 |
Posizioni attive di Richard Colvin
| Società | Posizione | Inizio |
|---|---|---|
| BLUEBIRD BIO, INC. | Chief Tech/Sci/R&D Officer | 01/03/2021 |
Precedenti posizioni note di Richard Colvin
| Società | Posizione | Fine |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Corporate Officer/Principal | - |
Formazione di Richard Colvin
| Cornell University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
- Borsa valori
- Insiders
- Richard Colvin
